Zevra Therapeutics, Inc. ZVRA Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireOtherInvestments.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s investment purchases?
- Zevra Therapeutics, Inc. (ZVRA) reported investment purchases of $58.3M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s investment purchases changed year-over-year?
- Zevra Therapeutics, Inc.'s investment purchases increased by 692.2% year-over-year, from $7.36M to $58.3M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s investment purchases?
- Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s investment purchases has grown at a 111.7% compound annual growth rate (CAGR), from $15.42M to $309.99M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.